Filtered By:
Management: Venture Capital
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 29 results found since Jan 2013.
Sensome, Formerly Instent, Raises 4.7m to Bring the World's First Connected Stroke Guidewire to Patients
Sensome's first application of its AI-powered micro-sensor technology can detect the composition of the blockage in the brain during stroke treatment
PARIS, July 17, 2017 -- (Healthcare Sales & Marketing Network) -- Sensome, formerly Instent, a company... Devices, Interventional, Venture Capital Sensome, Instent , guidewire, stroke
Source: HSMN NewsFeed - July 17, 2017 Category: Pharmaceuticals Source Type: news
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
MIAMI, Sept. 13, 2022 -- (Healthcare Sales & Marketing Network) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced that it has raised an additional $10.5 million, bri... Devices, Interventional, Neurology, Venture Capital RapidPulse, Cyclic Aspiration System, stroke
Source: HSMN NewsFeed - September 13, 2022 Category: Pharmaceuticals Source Type: news
Cleveland Clinic Selects Twiage as the Winner of 2015 New Ventures Healthcare Challenge
Cleveland, OH, October 26, 2015 – Cleveland Clinic Innovations selected Twiage, a novel prehospital communication solution that enables Emergency Departments to triage incoming ambulances, as the winner of its prestigious 3rd New Ventures Healthcare Challenge at the 2015 Medical Innovation Summit on Monday.
On Monday, Dr. YiDing Yu, Founder and Chief Medical Officer of Twiage, gave the winning pitch. “Nineteen million Americans will take an ambulance to Emergency Departments this year. For many, it will be a life-threatening event.” Dr. Yu described how a first responder can use Twiage to record video of stroke sympt...
Source: JEMS Administration and Leadership - October 26, 2015 Category: Emergency Medicine Tags: Leadership & Professionalism Technology Source Type: news
Ekso Bionics Steps Up to Develop Exoskeleton Market in Asia
China is expected to have 30 million stroke patients by 2030, and many of those patients will have some degree of disability. And yet, the stroke and spinal cord rehabilitation industry in China is not as developed as it is in the United States. A new joint venture between Ekso Bionics, Zhejiang Youchuang Venture Capital Investment (ZYVC) and Zhejiang Silicon Paradise Asset Management Group could change that.
"This joint venture is a transformative opportunity both for Ekso Bionics and for the millions of Chinese stroke and spinal cord injury patients who currently have limited access to advanced rehabilitation...
Source: MDDI - January 30, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Orthopedics Source Type: news
4 Key Insights When Raising Money for Your Medtech Startup: Interview with Bruce Shook, CEO of Intact Vascular
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them!
Bruce Shook joined Intact Vascular in 2014 as President and CEO. A highly-experienced, medical device executive with more than 30 years of industry experience, Bruce was previously Co-founder, Director, President, and CEO of Neuronetics, which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression.
Previously, Shook was Co-founder, Director, President, an...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Blog medsider Source Type: news
Philips, AHA, UPMC launch $30m heart-focused venture fund
Royal Philips (NYSE:PHG) said late last week it is joining with the American Heart Association and UPMC to launch a $30 million heart-focused collaborative venture capital fund.
The newly formed Cardeation Capital fund will support innovation in products for treating heart disease and stroke care. The fund will be managed by Aphelion Capital, with each major player contributing $10 million, Amsterdam-based Philips said.
Cardeation Capital will look to invest in companies trying to treat cardiovascular diseases and stroke and their risk factors, including diabetes, according to Philips.
“At Philips our goal is to imp...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Wall Street Beat American Heart Assn. royalphilips UPMC Source Type: news
Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.
OXFORD, England, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Brainomix, a medical imaging company using a... Devices, Neurology, Venture Capital Brainomix, Boehringer Ingelheim, stroke, e-ASPECTS
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news
Korean JLK Inspection launches AI-powered imaging diag system
Korean JLK Inspection said yesterday that it launched its AIHub artificial intelligence-powered medical image diagnostics platform.
The newly launched AIHub system is designed to analyze images from a number of different imaging modalities, including magnetic resonance imaging, computed tomography, X-ray and mammography, the Seoul-based company said.
JLK Inspection claims the system can detect and monitor for more than 30 medical conditions in 14 regions of the body. The company added that the system is focused on brain diseases and conditions including ischemic stroke, hemorrhagic stroke, brain aneurysm and Alzheimer̵...
Source: Mass Device - December 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Imaging Software / IT jlkinspection Source Type: news
UPDATE: Embolization coil maker Blockade Medical pulls in $2.2m
UPDATED Oct. 27, 2015, with comment from Blockade Medical.
Blockade Medical pulled in $2.2 million and is looking for another $5.8 million in a new round of equity financing, according to an SEC filing published today.
The round was joined by new investors TitanMed Capital and GP Healthcare Capital, as well as returning investors and other venture capital and private equity funds in the healthcare sector, Blockade Medical said.
Funds from the round will support commercialization efforts for the Barricade coil system, as well as the development of novel neurovascular devices to treat aneurysms, stroke and other conditions,...
Source: Mass Device - October 27, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Vascular Blockade Medical Source Type: news
HeartWare plunges on uncertainty around its next-gen MVAD pump
Shares of HeartWare International (NSDQ:HTWR) are down some 28% today after the implantable heart pump maker said it can’t predict when it will be able to get its next-generation MVAD program back on line.
Framingham, Mass.-based HeartWare said it expects to post sales of roughly $68 million for the 3 months ended Dec. 31, in line with the consensus forecast on Wall Street for $67.2 million. But the company said its still evaluating date from a CE Mark trial of the MVAD left ventricular assist device that was halted last fall, which it now says show evidence of blood clots in the pump. The incidence of pump thrombo...
Source: Mass Device - January 12, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Assist Devices Clinical Trials Wall Street Beat HeartWare International Inc. Source Type: news
Prehospital Notification Startup Takes One of the Top Prizes from 2016 Cornell Venture Challenge
Ithaca, NY, April 14th, 2016 – A judging panel of entrepreneur, venture capital and angel investors selected S.A.L.T., a medical diagnostic technology that a patient uses at home to monitor his/her 24-hour sodium levels in urine, and Twiage, a novel prehospital communication and ambulance triage solution that accelerates life-saving emergency care, as the two top place winners of the 2016 Cornell Venture Challenge.
John Hui, Twiage’s Head of Business Development, gave Twiage’s winning pitch, “Believe it or not, we are in the 21st Century, but radios are still the current standard of communication between ambulances...
Source: JEMS Administration and Leadership - May 12, 2016 Category: Emergency Medicine Tags: Industry News Communications & Dispatch Source Type: news
